Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: A Clinical Study of RC48-ADC Combined With Triplizumab For Treatment of Myometrial Invasive Bladder Cancer [Phase 2]
Phase 2 study investigating RC48-ADC in combination with Triplizumab for myometrial invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder [Phase 2]
Phase 2 trial update on Mycobacterium w for superficial transitional cell carcinoma of the bladder has completed recruitment.
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Prucalopride for Postoperative Ileus in Patients Undergoing Robot-assisted Laparoscopic Radical Cystectomy [Phase 2]
Phase 2 clinical trial update for prucalopride aimed at treating postoperative ileus in patients undergoing robot-assisted laparoscopic radi…
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy [Phase 2]
A Phase 2 study of pembrolizumab with gemcitabine and cisplatin as neoadjuvant therapy for bladder cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites [NA]
Clinical trial update for Canady Helios cold plasma scalpel at surgical margins and macroscopic tumor sites; status and results data are unc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial. [Phase 3]
A Phase 3 randomized controlled trial investigating a fast track protocol after radical cystectomy and urinary diversion for bladder cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder [Phase 2]
Phase 2 trial of durvalumab (Medi4736) for BCG-refractory urothelial carcinoma in situ of the bladder (terminated; results posted).
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: PF-03446962 in Relapsed or Refractory Urothelial Cancer [Phase 2]
Phase 2 clinical trial of PF-03446962 in relapsed or refractory urothelial cancer (transitional cell carcinoma of the bladder) has completed…
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer
A completed clinical trial studying perioperative hypogonadism in men undergoing radical cystoprostatectomy for bladder cancer with results …
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the Bladder [Phase 2]
A Phase 2 clinical trial update evaluating preoperative Bintrafusp Alfa in operable urothelial carcinoma of the bladder is in progress.
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of CG0070 Oncolytic Virus regimen for high-grade non-muscle invasive bladder cancer af…
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer [Phase 2]
Phase II trial evaluating temsirolimus as a second-line therapy in relapsed bladder cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer [Phase 3]
A Phase 3 clinical trial evaluating electromotive mitomycin-C (EMDA-MMC) to prevent recurrences in high-risk non-muscle-invasive bladder can…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: Comparison of Obturator Nerve Blockade and Neuromuscular Blockade [Phase 4]
A Phase 4 trial comparing obturator nerve blockade with neuromuscular blockade in cancer of the bladder has completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: Steps to Eliminate Postoperative Problems [NA]
A completed clinical trial update related to bladder cancer; results posted, details not specified.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract [Phase 2]
Phase 2 trial evaluating surgery plus combination chemotherapy and radiation therapy for cancer of the urinary tract (bladder cancer and rel…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2 trial evaluating avelumab with fluorouracil and mitomycin or with cisplatin and radiation therapy for muscle-invasive bladder cancer…
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial update for HX008 in BCG-unresponsive non-muscle invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: the Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors [Phase 2]
Phase 2 trial assessing efficacy and safety of LDP in patients with bladder cancer, renal carcinoma, and advanced penile carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Treatment of Recurrent Bladder Cancer With Dendritic Cells [Phase 2]
Phase 2 clinical trial evaluating dendritic cell therapy for recurrent bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors [Phase 2]
Phase 2 clinical trial evaluating tamoxifen for low/intermediate risk bladder tumors has completed, with results posted.
-
FDA approval · 2020-12-11FDA Approved: GEMCITABINE — Original Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Meitheal Pharmaceuticals' generic gemcitabine hydrochloride under an original ANDA.
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: A Phase Ⅱ Study of F520 in Patients With Urothelial Carcinoma [Phase 2]
Phase 2 study update for F520 in locally advanced or metastatic urothelial carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial Carcinoma [Phase 2]
Phase 2 clinical trial update on toripalimab with nab-paclitaxel with or without cisplatin as first-line treatment for urothelial carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma [Phase 2]
Phase 2 clinical trial evaluating genomics-guided therapy selection in advanced urothelial carcinoma/bladder cancer has completed with resul…